Insulin Resistance and Diabetes Mellitus in HIV-Infected Patients Receiving Antiretroviral Therapy-Reference-Cited by-同舟云学术

Insulin Resistance and Diabetes Mellitus in HIV-Infected Patients Receiving Antiretroviral Therapy

Published:2004-09 Issue:4 Volume:2 Page:241-250
ISSN:1540-4196
Container-title:Metabolic Syndrome and Related Disorders
language:en
Short-container-title:Metabolic Syndrome and Related Disorders

Author:

Calza Leonardo¹,Manfredi Roberto¹,Chiodo Francesco¹

Affiliation:

1. Department of Clinical and Experimental Medicine, Section of Infectious Diseases, "Alma Mater Studiorum" University of Bologna, S. Orsola Hospital, Bologna, Italy.

Publisher

Mary Ann Liebert Inc

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/met.2004.2.241

Reference57 articles.

1. HIV lipodystrophy

2. Hyperlipidaemia in patients with HIV-1 infection receiving highly active antiretroviral therapy: epidemiology, pathogenesis, clinical course and management

3. HIV Protease Inhibitors Acutely Impair Glucose-Stimulated Insulin Release

4. Dyslipidaemia associated with antiretroviral therapy in HIV-infected patients

5. Glucose Disorders Associated with HIV and its Drug Therapy

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk of Stroke Among HIV Patients: A Systematic Review and Meta-analysis of Global Studies and Associated Comorbidities;JAIDS Journal of Acquired Immune Deficiency Syndromes;2024-04-15

2. Alcohol use and dysglycemia among people living with human immunodeficiency virus (HIV) in the Alcohol & Metabolic Comorbidities in PLWH: Evidence Driven Interventions (ALIVE‐Ex) study;Alcoholism: Clinical and Experimental Research;2021-08-02

3. HIV-Associated Lipodystrophy and Lipoatrophy;Fundamentals of HIV Medicine 2021;2021-06

4. miRNA-218 Targets Lipin-1 and Glucose Transporter Type 4 Genes in 3T3-L1 Cells Treated With Lopinavir/Ritonavir;Frontiers in Pharmacology;2019-04-30

5. Improvement in insulin sensitivity and serum leptin concentration after the switch from a ritonavir-boosted PI to raltegravir or dolutegravir in non-diabetic HIV-infected patients;Journal of Antimicrobial Chemotherapy;2018-12-12